Alterations in Serum Electrolytes in Cannabis and Amphetamine Use Disorders: A Comparative Clinical Study
Actas Españolas de Psiquiatría · 29.10.2026 · 1-13
DOI: 10.62641/aep.2390 ↗Kurz gefasst
Fachartikel in der Zeitschrift Actas Españolas de Psiquiatría, online erschienen am 29.10.2026. Verfasst von Sary Alsanea und 12 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Amphetamine and cannabis use disorders are common due to recreational use and are linked to altered metabolomic and proteomic profiles. Chronic exposure to these substances may affect human physiological functions. Since serum electrolytes play a key role in these functions, this study aimed to investigate the effects of single or combined use of amphetamine and/or cannabis on serum electrolyte levels.
Methods
Blood electrolyte and kidney function parameters were measured using clinical chemistry and immunoassay techniques. Serum oxidative stress markers (catalase and superoxide dismutase (SOD)) were also analyzed. Participants were divided into four groups: controls, cannabis users, amphetamine users, and cannabis-amphetamine users.
Results
No significant differences in kidney function were observed across the groups. However, phosphorus levels were elevated in the cannabis (t = 4.748, p < 0.001), amphetamine (t = 2.933, p < 0.05), and cannabis-amphetamine(t =3.364, p < 0.05)groups compared to controls. Moreover, sodium (t = 3.931, p < 0.01), chloride (t = 3.382, p < 0.05), and calcium (t = 3.391, p < 0.05) levels were significantly higher in the cannabis group compared to the control group. Patients with amphetamine (t = 4.311, p < 0.001) or cannabis (t = 4.738, p < 0.001) use disorder showed reduced catalase levels, with more pronounced reductions in those with combined use (t = 8.700, p < 0.0001). As compared to controls, serum SOD levels were also lower in patients with amphetamine (t = 6.957, p < 0.0001) or cannabis (t = 6.600, p < 0.0001) use disorder, with the greatest reduction observed in the combined-use group (t = 12.11, p < 0.0001).
Conclusions
Cannabis use disorder is associated with alterations in serum electrolytes while serum creatinine and urea levels remained within the measured range. Co-use of amphetamine and cannabis was associated with greater oxidative stress than the use of either drug alone. Further studies are needed to explore the molecular mechanisms involved in these changes.
Zitieren
APA
Alsanea, S., Alhamdan, M. M., Alotaibi, W. H., Al-Alallah, I. A., Hammad, A. M., Al-Qerem, W., Alhazzani, K., AlAsmari, A. F., Alzarea, S. I., Qamar, W., Algodimi, A. M., Imran, I., & Alasmari, F. (2026). Alterations in Serum Electrolytes in Cannabis and Amphetamine Use Disorders: A Comparative Clinical Study. Actas Españolas de Psiquiatría, 1-13. https://doi.org/10.62641/aep.2390
Vancouver
Alsanea S, Alhamdan MM, Alotaibi WH, Al-Alallah IA, Hammad AM, Al-Qerem W, et al. Alterations in Serum Electrolytes in Cannabis and Amphetamine Use Disorders: A Comparative Clinical Study. Actas Españolas de Psiquiatría. 2026:1-13. doi:10.62641/aep.2390
BibTeX
@article{Alsanea2026,
author = {Alsanea, Sary and Alhamdan, Majd M. and Alotaibi, Wedad H. and Al-Alallah, Ibrahim A. and Hammad, Alaa M. and Al-Qerem, Walid and Alhazzani, Khalid and AlAsmari, Abdullah F. and Alzarea, Sami I. and Qamar, Wajhul and Algodimi, Ali M. and Imran, Imran and Alasmari, Fawaz},
title = {Alterations in Serum Electrolytes in Cannabis and Amphetamine Use Disorders: A Comparative Clinical Study},
journal = {Actas Españolas de Psiquiatría},
year = {2026},
pages = {1--13},
doi = {10.62641/aep.2390}
}
EUVIMED